IndraLab

Statements


Modified USP9X leads to the deubiquitination of SMAD4. 3 / 3
| 3

reach
"Strikingly, overexpression of wild-type FAM, but not of the catalytically inactive FAM mutant, inhibited Smad4 monoubiquitination in vivo."

reach
"Loss of USP9X therefore prevents deubiquitination of SMAD4, enhancing tumour progression."

reach
"Overexpression of FAM also inhibits monoubiquitination of endogenous Smad4."